Literature DB >> 8604434

The pharmacology of galanthamine and its analogues.

A L Harvey1.   

Abstract

Galanthamine is an alkaloid found in the bulbs of snowdrops and several Amaryllidaceae plants. At submicromolar concentrations, it inhibits acetylcholinesterase activity, but it is much less potent against butyrylcholinesterase activity. Galanthamine has been used in anaesthetics to reverse neuromuscular paralysis by tubocurarine-like muscle relaxants, but it is a tertiary amine that gets into the brain to cause central effects. Galanthamine is being studied as a possible therapeutic agent in Alzheimer's disease because of its central cholinergic effects. Positive effects have been demonstrated in several learning and memory tests in animals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8604434     DOI: 10.1016/0163-7258(95)02002-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  27 in total

1.  Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.

Authors:  Thomas J Hopkins; Laura E Rupprecht; Matthew R Hayes; Julie A Blendy; Heath D Schmidt
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.

Authors:  Derek S Wilkinson; Thomas J Gould
Journal:  Behav Brain Res       Date:  2011-04-14       Impact factor: 3.332

Review 3.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

4.  Molecular docking study on the "back door" hypothesis for product clearance in acetylcholinesterase.

Authors:  Laleh Alisaraie; Gregor Fels
Journal:  J Mol Model       Date:  2005-12-09       Impact factor: 1.810

Review 5.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 6.  Neuromuscular transmission and its pharmacological blockade. Part 3: Continuous infusion of relaxants and reversal and monitoring of relaxation.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

7.  Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats.

Authors:  Blake A Kimmey; Laura E Rupprecht; Matthew R Hayes; Heath D Schmidt
Journal:  Addict Biol       Date:  2012-12-12       Impact factor: 4.280

8.  Positive allosteric modulator of α7 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates.

Authors:  Patrick M Callahan; Elizabeth J Hutchings; Nancy J Kille; James M Chapman; Alvin V Terry
Journal:  Neuropharmacology       Date:  2012-11-17       Impact factor: 5.250

9.  Impact of modulation of the α7 nicotinic acetylcholine receptor on nicotine reward in the mouse conditioned place preference test.

Authors:  Asti Jackson; Y Alkhlaif; R L Papke; D H Brunzell; M I Damaj
Journal:  Psychopharmacology (Berl)       Date:  2019-07-13       Impact factor: 4.530

10.  Molecular recognition between 4a S/R-galanthamine diastereoisomers and alpha-cyclodextrin.

Authors:  Ming Sun; Xiaohong Liu; Liushui Yan; Guoan Luo; Yufen Zhao
Journal:  J Mol Model       Date:  2003-10-07       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.